Outlook Therapeutics, Inc.

OTLK · XNAS

CIK 1649989fmd_1J9RJQW3S8SW7STQZSDCTM8YMGManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Oct 01, 2014 to Jun 30, 2026, 46 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.